KannaLife™ Sciences currently holds an exclusive license with the National Institutes of Health – Office of Technology Transfer (“NIH-OTT”) for the commercialization of U.S. Patent #6,630,507, “Cannabinoids as Antioxidants and Neuroprotectants” (the “‘507 Patent”). - See more at: http://medicalmarijuanainc.com/companies/kannalife/#sthash.gRMpqGk8.dpuf